社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Moderna, Inc.(MRNA)
盘前
31.64
0.38
+1.22%
06:06 EDT
31.26
-0.94
-2.92%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
Moderna, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.modernatx.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸（信使核糖核酸）医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年，该公司以前所未有的速度和效率开发出药物，包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队，以负责任的方式改变人类健康的未来，该公司努力通过mRNA药物向人们传递尽可能大的影响。
06-11
关联方拟减持公告
Form 144 | Moderna, Inc.董事 Hussain Abbas 拟减持312股，总价约8736美元
Form 144 | Moderna, Inc.董事 Hussain Abbas 拟减持312股，总价约8736美元
05-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-01
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05-01
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-21
年度报告
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
02-21
员工持股计划
Form S-8 - Securities to be offered to employees in employee benefit plans
Form S-8 - Securities to be offered to employees in employee benefit plans
02-14
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-13
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2024-12-09
关联方拟减持公告
Form 144 | Moderna, Inc. 高管 Shannon Klinger 拟减持529股，总价约23637美元
Form 144 | Moderna, Inc. 高管 Shannon Klinger 拟减持529股，总价约23637美元
2024-12-03
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2024-12-03
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2024-11-29
关联方拟减持公告
Form 144 | Moderna高管 Stephen Hoge 拟减持291股，总价约12451美元
Form 144 | Moderna高管 Stephen Hoge 拟减持291股，总价约12451美元
2024-11-29
关联方拟减持公告
Form 144 | Moderna高管Klinger Shannon拟减持1418股，总价约60674.95美元
Form 144 | Moderna高管Klinger Shannon拟减持1418股，总价约60674.95美元
2024-11-29
关联方拟减持公告
Form 144 | Moderna高管 James Mock 拟减持1420股，总价约6.08万美元
Form 144 | Moderna高管 James Mock 拟减持1420股，总价约6.08万美元
2024-11-12
关联方拟减持公告
Form 144 | Moderna高管 Stephen Hoge 拟减持277股，总价约1.28万美元
Form 144 | Moderna高管 Stephen Hoge 拟减持277股，总价约1.28万美元
分时
5日
日
周
月
数据加载中...
最高
32.58
今开
32.45
量比
1.13
最低
30.97
昨收
32.20
换手率
2.17%
热议股票
{"pagemeta":{"title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moderna, Inc.,MRNA,Moderna, Inc.股票,Moderna, Inc.股票老虎,Moderna, Inc.股票老虎国际,Moderna, Inc.行情,Moderna, Inc.股票行情,Moderna, Inc.股价,Moderna, Inc.股市,Moderna, Inc.股票价格,Moderna, Inc.股票交易,Moderna, Inc.股票购买,Moderna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"MRNA","data":{"stockData":{"symbol":"MRNA","market":"US","secType":"STK","nameCN":"Moderna, Inc.","latestPrice":31.26,"timestamp":1752868800000,"preClose":32.2,"halted":0,"volume":7823637,"hourTrading":{"tag":"盘前","latestPrice":31.64,"preClose":31.26,"latestTime":"06:06 EDT","volume":3050,"amount":96391.2057,"timestamp":1753092407531},"delay":0,"floatShares":360969422,"shares":386741820,"eps":-8.726025,"marketStatus":"盘前交易","change":-0.94,"latestTime":"07-21 06:14:38 EDT","open":32.45,"high":32.58,"low":30.97,"amount":246476376.408042,"amplitude":0.05,"askPrice":31.69,"askSize":20,"bidPrice":31.55,"bidSize":121,"shortable":3,"etf":0,"ttmEps":-8.726025,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753104600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1544158800000,"exchange":"NASDAQ","adjPreClose":31.26,"preHourTrading":{"tag":"盘前","latestPrice":31.64,"preClose":31.26,"latestTime":"06:06 EDT","volume":3050,"amount":96391.2057,"timestamp":1753092407531},"postHourTrading":{"tag":"盘后","latestPrice":31.25,"preClose":31.26,"latestTime":"19:59 EDT","volume":317417,"amount":9921096.114735,"timestamp":1752883173348},"volumeRatio":1.1272946093147287,"optionData":{"bulkOrders":[{"symbol":"MRNA","call":true,"expireDate":1768539600000,"strike":"35.0","timestamp":1752862340242,"price":4.25,"volume":1336,"amount":567800,"type":"-"}]},"impliedVol":0.6642,"impliedVolPercentile":0.1807},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"19760895","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917325003978-MRNA","pdf_url":"","pub_time":1749614400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 | Moderna, Inc.董事 Hussain Abbas 拟减持312股，总价约8736美元","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917325003978/0001959173-25-003978-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"Form 144 | Moderna, Inc.董事 Hussain Abbas 拟减持312股，总价约8736美元","gpt_en_title":"Form 144 | Moderna, Inc. Director Hussain Abbas proposes to sell 312 Shares, with a total value of approximately $8736.","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917325003978/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE2ku4Miv9W1sZo9mY","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2025-06-11 12:00","pubTimestamp":1749614400,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","is_gpt_notice":1,"gpt_icon":1},{"cdn_pdf":false,"hasAttachments":true,"id":"19598723","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285225000036-MRNA","pdf_url":"","pub_time":1746417600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000036/0001682852-25-000036-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000036/mrna-20250430.htm","primary":true,"translateUrl":"","linkName":"mrna-20250430.htm","type":"8-K","id":"NTFILEEdJHh7LvTwznzpmh","market":"us","size":40233}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-05-05 12:00","pubTimestamp":1746417600,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"项目5.07：将事项提交证券持有人表决","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19590525","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285225000034-MRNA","pdf_url":"","pub_time":1746072000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"MRNA","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000034/0001682852-25-000034-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000034/mrna-20250331.htm","primary":true,"translateUrl":"","linkName":"mrna-20250331.htm","type":"10-Q","id":"NTFILEwuPV33LNVdkbxiBH","market":"us","size":1177574},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000034/exhibit3113312025.htm","primary":false,"translateUrl":"","linkName":"exhibit3113312025.htm","type":"EX-31.1","id":"NTFILEGjhNwYAirScv6mSm","market":"us","size":9144},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000034/exhibit3123312025.htm","primary":false,"translateUrl":"","linkName":"exhibit3123312025.htm","type":"EX-31.2","id":"NTFILEB858buo4pqjyjzcz","market":"us","size":9089},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000034/exhibit3213312025.htm","primary":false,"translateUrl":"","linkName":"exhibit3213312025.htm","type":"EX-32.1","id":"NTFILEBb5miX3JrEVTvvNZ","market":"us","size":8219},{"description":"null","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000034/mrna-20250331_g1.jpg","primary":false,"translateUrl":"","linkName":"mrna-20250331_g1.jpg","type":"GRAPHIC","id":"NTFILE8xphbEbir3tpVf1S","market":"us","size":63925},{"description":"null","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000034/mrna-20250331_g2.jpg","primary":false,"translateUrl":"","linkName":"mrna-20250331_g2.jpg","type":"GRAPHIC","id":"NTFILEEo51q2zvKxCU8vCf","market":"us","size":335475}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-05-01 12:00","pubTimestamp":1746072000,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19589322","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285225000031-MRNA","pdf_url":"","pub_time":1746072000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000031/0001682852-25-000031-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000031/exhibit9912025q1pressrelea.htm","primary":true,"translateUrl":"","linkName":"exhibit9912025q1pressrelea.htm","type":"EX-99.1","id":"NTFILEHaXqkAwgG7D8ansd","market":"us","size":150435},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000031/mrna-20250501.htm","primary":false,"translateUrl":"","linkName":"mrna-20250501.htm","type":"8-K","id":"NTFILE5D5KiS48bcvMbJmu","market":"us","size":30223}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-05-01 12:00","pubTimestamp":1746072000,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19134653","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285225000022-MRNA","pdf_url":"","pub_time":1740114000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"MRNA","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/mrna-20241231.htm","primary":true,"translateUrl":"","linkName":"mrna-20241231.htm","type":"10-K","id":"NTFILE6E4SRdvRMxgunqjj","market":"us","size":2713266},{"description":"EX-4.2","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/exhibit4212312024.htm","primary":false,"translateUrl":"","linkName":"exhibit4212312024.htm","type":"EX-4.2","id":"NTFILE3zMWPkwxgpHNzioo","market":"us","size":20811},{"description":"EX-19","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/exhibit19insidertradingpol.htm","primary":false,"translateUrl":"","linkName":"exhibit19insidertradingpol.htm","type":"EX-19","id":"NTFILECwjJHDhZp8RixCD5","market":"us","size":43199},{"description":"EX-21.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/exhibit211subsidiaries2024.htm","primary":false,"translateUrl":"","linkName":"exhibit211subsidiaries2024.htm","type":"EX-21.1","id":"NTFILE4f6pgDHPRdgVpQcn","market":"us","size":17184},{"description":"EX-23.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/exhibit23112312024.htm","primary":false,"translateUrl":"","linkName":"exhibit23112312024.htm","type":"EX-23.1","id":"NTFILE5MHzMVAfvFq7419X","market":"us","size":5074},{"description":"EX-31.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/exhibit31112312024.htm","primary":false,"translateUrl":"","linkName":"exhibit31112312024.htm","type":"EX-31.1","id":"NTFILE9urmsnHG89xKZamB","market":"us","size":9565},{"description":"EX-31.2","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/exhibit31212312024.htm","primary":false,"translateUrl":"","linkName":"exhibit31212312024.htm","type":"EX-31.2","id":"NTFILE9HCojQ4mMSw8NcnF","market":"us","size":9241},{"description":"EX-32.1","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/exhibit32112312024.htm","primary":false,"translateUrl":"","linkName":"exhibit32112312024.htm","type":"EX-32.1","id":"NTFILECKL4AMUfwPeAGrcv","market":"us","size":6564},{"description":"EX-32.2","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/exhibit32212312024.htm","primary":false,"translateUrl":"","linkName":"exhibit32212312024.htm","type":"EX-32.2","id":"NTFILE6RTTqymS6rb7eJ5j","market":"us","size":6551},{"description":"","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/image_0.jpg","primary":false,"translateUrl":"","linkName":"image_0.jpg","type":"GRAPHIC","id":"NTFILE71FzZyxiyBC4FVST","market":"us","size":21831},{"description":"","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/mrna-20241231_g1.jpg","primary":false,"translateUrl":"","linkName":"mrna-20241231_g1.jpg","type":"GRAPHIC","id":"NTFILE3exMqqiD22B3o3T1","market":"us","size":63925},{"description":"","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/mrna-20241231_g2.jpg","primary":false,"translateUrl":"","linkName":"mrna-20241231_g2.jpg","type":"GRAPHIC","id":"NTFILEA5JPhUrroHRHRyXs","market":"us","size":54660},{"description":"","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/mrna-20241231_g3.jpg","primary":false,"translateUrl":"","linkName":"mrna-20241231_g3.jpg","type":"GRAPHIC","id":"NTFILEAcgD93KmjXc4akxd","market":"us","size":120464},{"description":"","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/mrna-20241231_g4.jpg","primary":false,"translateUrl":"","linkName":"mrna-20241231_g4.jpg","type":"GRAPHIC","id":"NTFILEBiJrSrMp28fksEq6","market":"us","size":755114},{"description":"","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/mrna-20241231_g5.jpg","primary":false,"translateUrl":"","linkName":"mrna-20241231_g5.jpg","type":"GRAPHIC","id":"NTFILE61cZxJkp8pD57WNv","market":"us","size":344799},{"description":"","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000022/mrna-20241231_g6.jpg","primary":false,"translateUrl":"","linkName":"mrna-20241231_g6.jpg","type":"GRAPHIC","id":"NTFILE7eLkRfHbcEdiRKE1","market":"us","size":156108}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2025-02-21 13:00","pubTimestamp":1740114000,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19134652","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285225000023-MRNA","pdf_url":"","pub_time":1740114000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"MRNA","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000023/0001682852-25-000023-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000023/modernaforms-8feb2025.htm","primary":true,"translateUrl":"","linkName":"modernaforms-8feb2025.htm","type":"S-8","id":"NTFILE65tXNnS9b8xsfBtV","market":"us","size":48779},{"description":"EX-FILING FEES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000023/exfilingfees.htm","primary":false,"translateUrl":"","linkName":"exfilingfees.htm","type":"EX-FILING FEES","id":"NTFILECsWYyafGhvHJ3iys","market":"us","size":13386},{"description":"EX-5.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000023/exhibit51opinionfors-8gp21.htm","primary":false,"translateUrl":"","linkName":"exhibit51opinionfors-8gp21.htm","type":"EX-5.1","id":"NTFILEDi6yF1TVY2KFDRK1","market":"us","size":8766},{"description":"EX-23.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000023/exhibit231eys-8consent.htm","primary":false,"translateUrl":"","linkName":"exhibit231eys-8consent.htm","type":"EX-23.1","id":"NTFILEAvV5Vky6SLF7soUn","market":"us","size":2555},{"description":"","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000023/image_0a.jpg","primary":false,"translateUrl":"","linkName":"image_0a.jpg","type":"GRAPHIC","id":"NTFILEDVReSYmcYXh7EZo8","market":"us","size":13323}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2025-02-21 13:00","pubTimestamp":1740114000,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19114138","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285225000006-MRNA","pdf_url":"","pub_time":1739509200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000006/0001682852-25-000006-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000006/exhibit9912024q4pressrelea.htm","primary":true,"translateUrl":"","linkName":"exhibit9912024q4pressrelea.htm","type":"EX-99.1","id":"NTFILE6SbzkR1oWuVVP3Yn","market":"us","size":176417},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000006/mrna-20250214.htm","primary":false,"translateUrl":"","linkName":"mrna-20250214.htm","type":"8-K","id":"NTFILE7nWGpSJo5jeGb24L","market":"us","size":30513}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-02-14 13:00","pubTimestamp":1739509200,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目2.02：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19037646","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285225000002-MRNA","pdf_url":"","pub_time":1736744400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000002/0001682852-25-000002-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000002/exhibit991-01132025.htm","primary":true,"translateUrl":"","linkName":"exhibit991-01132025.htm","type":"EX-99.1","id":"NTFILECJBW9Z746Uunxx9w","market":"us","size":27138},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000002/mrna-20250113.htm","primary":false,"translateUrl":"","linkName":"mrna-20250113.htm","type":"8-K","id":"NTFILE8d9znXDk8Kfq76J2","market":"us","size":31248}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-01-13 13:00","pubTimestamp":1736744400,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18922269","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917324008523-MRNA","pdf_url":"","pub_time":1733720400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 | Moderna, Inc. 高管 Shannon Klinger 拟减持529股，总价约23637美元","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324008523/0001959173-24-008523-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"Form 144 | Moderna, Inc. 高管 Shannon Klinger 拟减持529股，总价约23637美元","gpt_en_title":"Form 144 | Moderna, Inc.'s Officer Shannon Klinger proposes to sell 529 Shares, with a total value of approximately $23,637.31.","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324008523/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE4CjGimZHGRJtmYGm","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-12-09 13:00","pubTimestamp":1733720400,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","is_gpt_notice":1,"gpt_icon":1},{"cdn_pdf":false,"hasAttachments":true,"id":"18901738","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917324008411-MRNA","pdf_url":"","pub_time":1733202000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324008411/0001959173-24-008411-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324008411/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE5KFHC1mYpQNHxMv5","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-12-03 13:00","pubTimestamp":1733202000,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18901519","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917324008401-MRNA","pdf_url":"","pub_time":1733202000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324008401/0001959173-24-008401-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324008401/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEAXmTrXvktuPs1zaf","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-12-03 13:00","pubTimestamp":1733202000,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18890108","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917324008285-MRNA","pdf_url":"","pub_time":1732856400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 | Moderna高管 Stephen Hoge 拟减持291股，总价约12451美元","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324008285/0001959173-24-008285-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"Form 144 | Moderna高管 Stephen Hoge 拟减持291股，总价约12451美元","gpt_en_title":"Form 144 | Moderna's Officer Stephen Hoge proposes to sell 291 Shares, with a total value of approximately $12,451.","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324008285/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE1bWKvxfzoPke36s4","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-11-29 13:00","pubTimestamp":1732856400,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","is_gpt_notice":1,"gpt_icon":1},{"cdn_pdf":false,"hasAttachments":true,"id":"18890097","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917324008284-MRNA","pdf_url":"","pub_time":1732856400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 | Moderna高管Klinger Shannon拟减持1418股，总价约60674.95美元","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324008284/0001959173-24-008284-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"Form 144 | Moderna高管Klinger Shannon拟减持1418股，总价约60674.95美元","gpt_en_title":"Form 144 | Moderna's Officer Klinger Shannon proposes to sell 1418 shares, with a total value of approximately $60674.95.","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324008284/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEGxwTyAAUG26nMbXs","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-11-29 13:00","pubTimestamp":1732856400,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","is_gpt_notice":1,"gpt_icon":1},{"cdn_pdf":false,"hasAttachments":true,"id":"18890076","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917324008281-MRNA","pdf_url":"","pub_time":1732856400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 | Moderna高管 James Mock 拟减持1420股，总价约6.08万美元","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324008281/0001959173-24-008281-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"Form 144 | Moderna高管 James Mock 拟减持1420股，总价约6.08万美元","gpt_en_title":"Form 144 | Moderna's Officer James Mock proposes to sell 1420 shares, with a total value of approximately $60,760.52.","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324008281/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE2pJFhFUYGn2BgUd4","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-11-29 13:00","pubTimestamp":1732856400,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","is_gpt_notice":1,"gpt_icon":1},{"cdn_pdf":false,"hasAttachments":true,"id":"18819913","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917324007672-MRNA","pdf_url":"","pub_time":1731387600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 | Moderna高管 Stephen Hoge 拟减持277股，总价约1.28万美元","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324007672/0001959173-24-007672-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"Form 144 | Moderna高管 Stephen Hoge 拟减持277股，总价约1.28万美元","gpt_en_title":"Form 144 | Moderna's Officer Stephen Hoge proposes to sell 277 Shares, with a total value of approximately $12,771.","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917324007672/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE29KqH6fwkcDhHGks","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-11-12 13:00","pubTimestamp":1731387600,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","is_gpt_notice":1,"gpt_icon":1}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.modernatx.com","stockEarnings":[{"period":"1week","weight":-0.0707},{"period":"1month","weight":0.2307},{"period":"3month","weight":0.2648},{"period":"6month","weight":-0.0822},{"period":"1year","weight":-0.7423},{"period":"ytd","weight":-0.2482}],"compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0504},{"period":"3month","weight":0.1922},{"period":"6month","weight":0.0502},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.0708}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸（信使核糖核酸）医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年，该公司以前所未有的速度和效率开发出药物，包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队，以负责任的方式改变人类健康的未来，该公司努力通过mRNA药物向人们传递尽可能大的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.057743},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.012362},{"month":3,"riseRate":0.571429,"avgChangeRate":0.028598},{"month":4,"riseRate":0.714286,"avgChangeRate":0.123955},{"month":5,"riseRate":0.571429,"avgChangeRate":0.06219},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.025027},{"month":7,"riseRate":0.714286,"avgChangeRate":0.115386},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.073656},{"month":9,"riseRate":0.5,"avgChangeRate":-0.034163},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.046191},{"month":11,"riseRate":0.833333,"avgChangeRate":0.247575},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.061337}],"exchange":"NASDAQ","name":"Moderna, Inc.","nameEN":"Moderna, Inc."},"aProfile":null}}}